142 related articles for article (PubMed ID: 32588322)
21. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
22. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 infection in reactive lymphoid tissues: a model for KSHV/HHV-8-related lymphomas?
Lazzi S; Bellan C; Amato T; Palummo N; Cardone C; D'Amuri A; De Luca F; Beyanga M; Facchetti F; Tosi P; Leoncini L
Hum Pathol; 2006 Jan; 37(1):23-31. PubMed ID: 16360412
[TBL] [Abstract][Full Text] [Related]
23. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling.
Zeng Y; Zhang X; Huang Z; Cheng L; Yao S; Qin D; Chen X; Tang Q; Lv Z; Zhang L; Lu C
J Virol; 2007 Mar; 81(5):2401-17. PubMed ID: 17151125
[TBL] [Abstract][Full Text] [Related]
24. Etiology of AIDS-related Kaposi's sarcoma and lymphoma.
Boshoff C; Whitby D; Talbot S; Weiss RA
Oral Dis; 1997 May; 3 Suppl 1():S129-32. PubMed ID: 9456674
[TBL] [Abstract][Full Text] [Related]
25. Cellular and viral oncogenes: the key to unlocking unknowns of Kaposi's sarcoma-associated herpesvirus pathogenesis.
Hussein HAM; Okafor IB; Walker LR; Abdel-Raouf UM; Akula SM
Arch Virol; 2018 Oct; 163(10):2633-2643. PubMed ID: 29936609
[TBL] [Abstract][Full Text] [Related]
26. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus.
Raggo C; Ruhl R; McAllister S; Koon H; Dezube BJ; Früh K; Moses AV
Cancer Res; 2005 Jun; 65(12):5084-95. PubMed ID: 15958552
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children.
Olp LN; Minhas V; Gondwe C; Poppe LK; Rogers AM; Kankasa C; West JT; Wood C
J Med Virol; 2016 Nov; 88(11):1973-81. PubMed ID: 27062052
[TBL] [Abstract][Full Text] [Related]
28. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
29. Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.
Staudt MR; Dittmer DP
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):129-35. PubMed ID: 12769790
[TBL] [Abstract][Full Text] [Related]
30. Induction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.
Dai L; Chen Y; Bonstaff K; Doyle L; Toole B; Parsons C; Qin Z
Cancer Lett; 2015 Jul; 362(2):158-66. PubMed ID: 25837851
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
32. Lymphomas occurring specifically in HIV-infected patients: from pathogenesis to pathology.
Gloghini A; Dolcetti R; Carbone A
Semin Cancer Biol; 2013 Dec; 23(6):457-67. PubMed ID: 23999127
[TBL] [Abstract][Full Text] [Related]
33. Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis.
Moore PS; Chang Y
J Natl Cancer Inst Monogr; 1998; (23):65-71. PubMed ID: 9709306
[TBL] [Abstract][Full Text] [Related]
34. Infection of KSHV and Interaction with HIV: The Bad Romance.
Qin J; Lu C
Adv Exp Med Biol; 2017; 1018():237-251. PubMed ID: 29052142
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation.
Merat R; Amara A; Lebbe C; de The H; Morel P; Saib A
Int J Cancer; 2002 Feb; 97(6):791-5. PubMed ID: 11857356
[TBL] [Abstract][Full Text] [Related]
36. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
Engels EA; Biggar RJ; Marshall VA; Walters MA; Gamache CJ; Whitby D; Goedert JJ
AIDS; 2003 Aug; 17(12):1847-51. PubMed ID: 12891072
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.
Miller G; Rigsby MO; Heston L; Grogan E; Sun R; Metroka C; Levy JA; Gao SJ; Chang Y; Moore P
N Engl J Med; 1996 May; 334(20):1292-7. PubMed ID: 8609946
[TBL] [Abstract][Full Text] [Related]
38. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
Smith CG; Kharkwal H; Wilson DW
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
[TBL] [Abstract][Full Text] [Related]
39. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology.
McAllister SC; Moses AV
Curr Top Microbiol Immunol; 2007; 312():211-44. PubMed ID: 17089799
[TBL] [Abstract][Full Text] [Related]
40. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.
Deloose ST; Smit LA; Pals FT; Kersten MJ; van Noesel CJ; Pals ST
Leukemia; 2005 May; 19(5):851-5. PubMed ID: 15744337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
